Correlation between Obesity and Contraceptive Method on Estrogen and Progesterone Receptors and Human Epidermal Growth Factor Receptor–2 Expression among Breast Cancer Patients in Dr. Moewardi Hospital, Surakarta
Abstract
Background: Breast cancer is the number 2 cancer in Indonesia after cervical cancer. Breast cancer increases every year. The formation of breast cancer is stimulated by various factors such as obesity and a history of family planning. In breast cancer, there are three important receptors, namely estrogen (ER) receptors, progesterone receptors (PR), and HER-2/Neu. The purpose of this study was to determine the association of obesity and history of family planning with the estrogen hormone receptor (ER), progesterone hormone receptor (PR), and HER-2/Neu expression in breast cancer patients in the dr. Moewardi Hospital in Surakarta, Central Java.
Subjects and Method: This was an analytic observational study carried out at Dr. Moewardi Hospital, Surakarta, Central Java. A sample of 117 pre- and post-menopausal women who performed examinations at the oncology surgical clinic at Dr. Moewardi hospital, Surakarta was selected by total sampling. The dependent variables were estrogen and progesterone receptors and HER-2/Neu expressions. The independent variables were obesity and history of contraceptive method. Data were obtained from the medical record and analyzed by multiple logistic regression.
Results: Obesity (OR= 0.29; 95% CI= 0.13 to 0.68; p= 0.004) reduced estrogen hormone receptors and it was statistically significant. History of contraceptive method (OR= 1.18; 95% CI= 0.55 to 2.52; p= 0.680) increased estrogen hormone receptors but it was not statistically significant. Obesity (OR=0.41; 95% CI= 0.18 to 0.96; p= 0.040) and history of contraceptive method (OR= 0.41; 95% CI= 0.19 to 0.88; p= 0.022) reduced progesterone hormone receptors. Obesity and history of contraceptive method increased Her-2/Neu expression.
Conclusion: Obesity reduces estrogen hormone receptors. History of the contraceptive method increases estrogen hormone receptors. Obesity and history of contraceptive method reduce progesterone hormone receptors. Obesity and history of contraceptive method increase Her-2/Neu expression.
Keywords: Obesity, contraceptive method, estrogen, progesterone hormones, Her-2/neu
Correspondence: Silvia Ari Agustina. Study Program in Midwifery, School of Health Sciences Achmad Yani, Yogyakarta. Jl. Ringroad Barat Ambarketawang, Gamping, Sleman, Yogyakarta. Phone: (0274) 4342000. Email: silvia_ari99@yahoo.com.
Indonesian Journal of Medicine (2019), 4(3): 259-265
https://doi.org/10.26911/theijmed.2019.04.03.09
References
Anakku (2014). Hormon Biang Keladi Kanker Payudara. Redaksi Majalah Anaku. Retrieved from http://www.anakku.net/hormon-biang-keladi-kanker-payudara.html.
Burstein HJ, Harris JR, Morrow M (2008). Malignant tumors of the breastin cancer principles practice of oncology. Devita VT, Lawrence TS, Rosenberg SA. (Wolters Kluwer Lippincott: Williams and Wilkins): 1606–54.
Daryono (2016). Tiap Bulan 500 Penderita Kanker Berobat ke RSUD Dr Moewardi. Retrieved from http://www.timlo.net/baca/68719656366/tiap-bulan-500-penderita-kanker-berobat-ke-rsud-dr-moewardi/.
Green LE, Dinh TH, Smith RA (2012). An estrogen model: The relationship between body mass index, menopausal status, estrogen replacement therapy, and breast cancer risk. Hindawi Publishing Corporation Computational and Mathematical Methods in Medicine:792375: 1-8. doi: 10.1155/2012/792375
Guyton AC, Hall JE (2008). Buku Ajar Fisiologi Kedokteran. Edisi 11. EGC. Jakarta
Hamdy et al., (2013). Obesity. Retrieved from www.medscape.com, 2013.
Kemenkes RI (2015). Situasi Penyakit Kanker. Buletin Jendela Kementerian Kesehatan RI. Jakarta
Kresnawan T (2012). Mengatur Makanan untuk Pencegahan danTerapi Kanker Payudara. Instalasi Gizi RSCM. Retrieved from http://gizi.depkes.go.id/wpcontent/uploads/2012/05/MENGATUR-MAKANAN-KANKER-PAYUDARA.pdf.
Kresno, Boedina S (2012). Ilmu Dasar Onkologi. Badan Penerbit FKUI. Jakarta.
Lincoln J, Wilensky (2008). Kanker payudara diagnosis dan solusinya. Prestasi Pustakaraya.Jakarta.
Lord, et al. (2008). Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: A case-control study. American Association for Cancer Research. Cancer Epidemiol Biomarkers Prev. 17(7).
Lorincz AM, Sukumar S (2006). Molecular linked between obesity and breast cancer. Retrieved from http://erc.endocrinologyjournals.org/cgi/content/full/13/2/279.
Macmillan Cancer Support (2011). Staging, grading, and receptors for breast cancer. Dalam: Macmillan Cancer Support, Understanding Breast Cancer.
Mulyani S (2013). Menopause akhir siklus menstruasi pada wanita di usia pertengahan. Nuha Medika.Yogyakarta
Nissa PAE, et al. (2017). Kontrasepsi hormonal sebagai faktor risiko kanker payudara di RSUD Al-Ihsan Bandung. Bandung Meeting on Global Medicine Health (BaMGMH), 1(1).
Prawirohardjo S (2011). Buku ilmu kandungan sarwono edisi ketiga. Jakarta: PT. Bina Pustaka Sarwono Prawirohardjo
Rahmawati A (2016). Hubungan antara penggunaan hormon eksogen terutama progesteron dengan ekspresi reseptor progesteron, estrogen, dan VEGF Pada Meningioma Orbitokranial Wanita. Electronic Theses and Dissertation (ETD) UGM: Yogyakarta
Rianti E, et al. (2012). Faktor-faktor yang berhubungan dengan risiko kanker payudara. Jurnal Health Quality, 3(1): 10
Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW, Hall P, Magnusson (2006). Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Association for Cancer Research. Cancer Epidemiol Biomarkers Prev. 15(12).
Saifuddin AB, et al. (2003). Buku panduan praktis pelayanan kontrasepasi. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo.
Sastrawinata S (2007). Obstetri patologi ilmu kesehatan reproduksi. Edisi 2. EGC. Jakarta.
Seidenfeld J, Samson DJ, Rothenberg BM, Bonnel CJ, Ziegler KM, Aronson N (2008). HER-2 Testing to Manage Patients with Breast Cancer or Other Solid Tumors. Evidence Report.
Setiowati DAI, Tanngo EH, Soebijanto RI. (2016. Hubungan antara Pemakaian kb hormonal dengan kejadian kanker payudara di poli Onkologi Satu Atap RSUD Dr. Soetomo, Februari–April 2015. Indonesian Journal of Cancer. 10(1): 11-17
Slamon DJ, Godolphin W, Jones LA, et al. (1989). Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science. 244: 707–712
Soroush A, Farschian N, Komasi S, Izadi N, Amirfrard N, Shahmohammadi A (2016). The roles of oral contraceptive pills on increased risk of breast cancer in Iranian Populations. J Cancer Prev. 21(4):294-301
Tang P, Wang X, Schiffhauer L, Wang J,Bourne P, Yang Q, et al. (2006). Expression patterns of ER-α, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and nonhigh grade ductal carcinoma in situ. Annals of Clinical Laboratory Science. 36(2).
Thor AD, Schwartz LH, Koerner FC, et al. (1989). Analysis of c-erbB-2 expression in breast carcinomas with clinical followup. Cancer Res. 49: 7147–7152
Widiasari E (2016). Hubungan penggunaan injeksi depot-medroxyprogesterone acetate (DMPA) dengan kadar estradiol pada penderita kanker payudara. Tesis Fakultas Kedokteran Spesialis Ilmu Bedah UNS: Surakarta.
